Discovery and Research
Uncovering Genomic Evidence of SARS-CoV-2 Infection and Reinfection
251 views
Joel Sevinsky, Principal at Theiagen Consulting, is an expert in bioinformatics in the public health space and coauthor of a recent paper exploring the genomics evidence for reinfection with SARS-CoV-2 that was published in The Lancet Infectious Diseases. In this webinar, Dr. Sevinsky will discuss:
How next-generation sequencing (NGS) and off-the-shelf software confirmed the first documented SARS-CoV-2 reinfection case in the United States;
How bioinformatics analysis strongly supports the hypothesis that the patient was infected on two separate occasions by genetically distinct viruses;
The rationale for the continued use of NGS-based approaches for analysis and surveillance of SARS-CoV-2 samples.
Leif Schauser, Global Product Manager at Qiagen Digital Insights, will discuss recent product developments at Qiagen that support the detection, NGS analysis, and interpretation SARS-CoV-2-positive samples, including stain typing. He will discuss solutions that range from Qiagen cloud-based services to scalable applications for on-premises analyses.
Related videos
Discovery and Research
Wastewater and COVID-19 data analysis using QIAGEN CLC Genomics Workbench
In this 90-minute training, users will learn how to easily analyze wastewater...
Discovery and Research
SARS-CoV-2 NGS surveillance & epidemiology with QIAGEN Digital Insights
This one-hour event will summarize our solutions for genomics research,...
Discovery and Research
Enabling High-Throughput Genomic Surveillance of Emerging SARS-CoV-2 Strains B.1.1.7 and B.1.351
In December 2020, the assumption that SARS-CoV-2 was a slowly-mutating virus...
Discovery and Research
From data to biological insight using QIAGEN CLC Single Cell Module and QIAGEN IPA: Single-cell...
Organ development during gestation is a complex series of hematopoietic...